171 related articles for article (PubMed ID: 21263191)
1. Analysis of volatile organic compounds (VOCs) in the headspace of NCI-H1666 lung cancer cells.
Sponring A; Filipiak W; Ager C; Schubert J; Miekisch W; Amann A; Troppmair J
Cancer Biomark; 2010; 7(3):153-61. PubMed ID: 21263191
[TBL] [Abstract][Full Text] [Related]
2. TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro.
Filipiak W; Sponring A; Filipiak A; Ager C; Schubert J; Miekisch W; Amann A; Troppmair J
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):182-95. PubMed ID: 20056637
[TBL] [Abstract][Full Text] [Related]
3. Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro.
Sponring A; Filipiak W; Mikoviny T; Ager C; Schubert J; Miekisch W; Amann A; Troppmair J
Anticancer Res; 2009 Jan; 29(1):419-26. PubMed ID: 19331181
[TBL] [Abstract][Full Text] [Related]
4. Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro.
Filipiak W; Sponring A; Mikoviny T; Ager C; Schubert J; Miekisch W; Amann A; Troppmair J
Cancer Cell Int; 2008 Nov; 8():17. PubMed ID: 19025629
[TBL] [Abstract][Full Text] [Related]
5. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
6. A novel polyaniline/polypyrrole/graphene oxide fiber for the determination of volatile organic compounds in headspace gas of lung cell lines.
Li J; Xu H
Talanta; 2017 May; 167():623-629. PubMed ID: 28340770
[TBL] [Abstract][Full Text] [Related]
7. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers.
Filipiak W; Filipiak A; Sponring A; Schmid T; Zelger B; Ager C; Klodzinska E; Denz H; Pizzini A; Lucciarini P; Jamnig H; Troppmair J; Amann A
J Breath Res; 2014 Jun; 8(2):027111. PubMed ID: 24862102
[TBL] [Abstract][Full Text] [Related]
8. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
9. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
10. Dynamic collection and analysis of volatile organic compounds from the headspace of cell cultures.
Baranska A; Smolinska A; Boots AW; Dallinga JW; van Schooten FJ
J Breath Res; 2015 Oct; 9(4):047102. PubMed ID: 26469548
[TBL] [Abstract][Full Text] [Related]
11. Urinary volatile compounds as biomarkers for lung cancer.
Hanai Y; Shimono K; Matsumura K; Vachani A; Albelda S; Yamazaki K; Beauchamp GK; Oka H
Biosci Biotechnol Biochem; 2012; 76(4):679-84. PubMed ID: 22484930
[TBL] [Abstract][Full Text] [Related]
12. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
[TBL] [Abstract][Full Text] [Related]
13. Application of an artificial neural network model for selection of potential lung cancer biomarkers.
Ligor T; Pater Ł; Buszewski B
J Breath Res; 2015 May; 9(2):027106. PubMed ID: 25944812
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of methyl tert-butyl ether, its degradation products and other gasoline additives in soil samples by closed-system purge-and-trap gas chromatography-mass spectrometry.
Rosell M; Lacorte S; Barceló D
J Chromatogr A; 2006 Nov; 1132(1-2):28-38. PubMed ID: 16904119
[TBL] [Abstract][Full Text] [Related]
15. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics.
Buszewski B; Ulanowska A; Kowalkowski T; Cieśliński K
Clin Chem Lab Med; 2011 Oct; 50(3):573-81. PubMed ID: 22035139
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.
Filipiak W; Sponring A; Baur MM; Filipiak A; Ager C; Wiesenhofer H; Nagl M; Troppmair J; Amann A
BMC Microbiol; 2012 Jun; 12():113. PubMed ID: 22716902
[TBL] [Abstract][Full Text] [Related]
17. Determination of volatile biomarkers for apoptosis and necrosis by solid-phase microextraction-gas chromatography/mass spectrometry: a pharmacometabolomic approach to cisplatin's cytotoxicity to human lung cancer cell lines.
Pyo JS; Ju HK; Park JH; Kwon SW
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):170-4. PubMed ID: 19027370
[TBL] [Abstract][Full Text] [Related]
18. Release of volatile organic compounds (VOCs) from colorectal cancer cell line LS174T.
Liu M; Li Y; Wang G; Guo N; Liu D; Li D; Guo L; Zheng X; Yu K; Yu K; Wang C
Anal Biochem; 2019 Sep; 581():113340. PubMed ID: 31226253
[TBL] [Abstract][Full Text] [Related]
19. Determination of volatile organic compounds exhaled by cell lines derived from hematological malignancies.
Tang H; Lu Y; Zhang L; Wu Z; Hou X; Xia H
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28507202
[TBL] [Abstract][Full Text] [Related]
20. [Determination of volatile organic compounds in lung cancer cell lines and lung cancer tissue].
Hu YJ; Qiu YH; Chen EG; Ying KJ; Yu J; Wang P
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 May; 39(3):278-84. PubMed ID: 20544990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
